Share：
Share this content in WeChat
X
[Chinese] [PDF] 67 2
• Review •
Research progress of magnetic resonance elastography in uterine tumors
ZHOU Xiaoqin  ZHONG Suixing  WANG Sisi  CHEN Junru  ZHANG Ya  AI Conghui 

DOI:10.12015/issn.1674-8034.2026.07.028.


[Abstract] Magnetic resonance elastography (MRE) is a non-invasive quantitative biomechanical imaging technique that assesses the mechanical properties of tissues, such as elasticity and viscosity. In recent years, MRE has been increasingly investigated in uterine fibroids, endometrial cancer, and cervical cancer, demonstrating its potential value in differentiating benign from malignant lesions and evaluating tumor aggressiveness. However, most studies are limited to small-sample explorations, lacking systematic summaries and integrated analyses of clinical application prospects. This article systematically reviews the imaging principles of MRE and its clinical application progress in common uterine tumors, analyzes its advantages and limitations, and discusses future directions, aiming to provide a theoretical reference and practical guidance for the use of MRE in precision imaging assessment of gynecological tumors.
[Keywords] uterine neoplasms；magnetic resonance imaging；elasticity imaging techniques；precision medicine

ZHOU Xiaoqin   ZHONG Suixing   WANG Sisi   CHEN Junru   ZHANG Ya   AI Conghui*  

Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming 650118, China

Corresponding author: AI C H, E-mail: aiconghui@kmmu.edu.cn

Conflicts of interest   None.

Received  2026-03-14
Accepted  2026-06-22
DOI: 10.12015/issn.1674-8034.2026.07.028
DOI:10.12015/issn.1674-8034.2026.07.028.

[1]
WANG B, PAN Y S, XU S C, et al. Quantitative cerebral blood volume image synthesis from standard MRI using image-to-image translation for brain tumors[J/OL]. Radiology, 2023, 308(2): e222471[2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/37581504/. DOI: 10.1148/radiol.222471.
[2]
ZHOU H Y, WANG M, ZHANG Y X, et al. Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis[J]. Cancer Commun (Lond), 2022, 42(5): 374-400. DOI: 10.1002/cac2.12294.
[3]
MO C K, LIU J X, CHEN S Q, et al. Tumour evolution and microenvironment interactions in 2D and 3D space[J]. Nature, 2024, 634(8036): 1178-1186. DOI: 10.1038/s41586-024-08087-4.
[4]
YUSHCHENKO M, SARRACANIE M, SALAMEH N. Fast acquisition of propagating waves in humans with low-field MRI: Toward accessible MR elastography[J/OL]. Sci Adv, 2022, 8(36): eabo5739 [2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/36083901/. DOI: 10.1126/sciadv.abo5739.
[5]
KIM B K, BERGSTROM J, LOOMBA R, et al. Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: a multicenter cohort study[J]. Hepatology, 2023, 78(6): 1858-1866. DOI: 10.1097/hep.0000000000000470.
[6]
ZHANG X Y, WANG X C. Research progress of magnetic resonance elastography in abdominal and pelvic cancer[J]. Chin J Magn Reson Imaging, 2024, 15(5): 216-221. DOI: 10.12015/issn.1674-8034.2024.05.035.
[7]
JIANG Z R, ZHANG H L, ZHU Z Y, et al. Advancements and applications of magnetic resonance elastography in chronic liver diseases[J]. Chin J Magn Reson Imaging, 2025, 16(3): 190-195. DOI: 10.12015/issn.1674-8034.2025.03.032.
[8]
LI J Y, FOO K Y, SANDERSON R W, et al. Visualization of breast cancer using contrast-enhanced optical coherence elastography based on tissue heterogeneity[J]. IEEE Trans Med Imaging, 2026, 45(1): 162-176. DOI: 10.1109/tmi.2025.3593507.
[9]
ALEEF T A, LOBO J, BAGHANI A, et al. Multi-frequency 3D shear wave absolute vibro-elastography (S-WAVE) system for the prostate[J]. IEEE Trans Med Imaging, 2023, 42(11): 3436-3450. DOI: 10.1109/TMI.2023.3288468.
[10]
SCHATTENFROH J, MEYER T, AGHAMIRY H S, et al. In vivo wideband MR elastography for assessing age-related viscoelasticity changes of the human brain[J]. Acta Biomater, 2026, 213: 508-520. DOI: 10.1016/j.actbio.2026.02.002.
[11]
GUO J, SAVIC L J, HILLEBRANDT K H, et al. MR elastography in cancer[J]. Invest Radiol, 2023, 58(8): 578-586. DOI: 10.1097/RLI.0000000000000971.
[12]
OBRZUT M, OBRZUT B, ZMUDA M, et al. Uterine leiomyomas: correlation between histologic composition and stiffness via magnetic resonance elastography - a Pilot Study[J]. Ginekol Pol, 2020, 91(7): 373-378. DOI: 10.5603/GP.a2020.0067.
[13]
KOL S Q, WASSENAAR N P M, DE LEEUW R A, et al. Magnetic resonance elastography (MRE) for the evaluation of fibrosis in patients with benign uterine disorders: a systematic review[J/OL]. Abdom Radiol, 2026: [2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/41642287/. DOI: 10.1007/s00261-026-05374-8.
[14]
STEWART E A, TARAN F A, CHEN J, et al. Magnetic resonance elastography of uterine leiomyomas: a feasibility study[J]. Fertil Steril, 2011, 95(1): 281-284. DOI: 10.1016/j.fertnstert.2010.06.004.
[15]
ICHIKAWA S, MOTOSUGI U, OMORI M, et al. MR-guided focused ultrasound for uterine fibroids: a preliminary study of relationship between the treatment outcomes and factors of MR images including elastography[J]. Magn Reson Med Sci, 2019, 18(1): 82-87. DOI: 10.2463/mrms.tn.2017-0103.
[16]
JONDAL D E, WANG J, CHEN J, et al. Uterine fibroids: correlations between MRI appearance and stiffness via magnetic resonance elastography[J]. Abdom Radiol, 2018, 43(6): 1456-1463. DOI: 10.1007/s00261-017-1314-1.
[17]
ZHANG L Q, LONG X, NIJIATI M, et al. Tumor stiffness measured by 3D magnetic resonance elastography can help predict the aggressiveness of endometrial carcinoma: preliminary findings[J/OL]. Cancer Imaging, 2021, 21(1): 50 [2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/34454623/. DOI: 10.1186/s40644-021-00420-8.
[18]
LONG L, LIU M L, DENG X J, et al. 3D multifrequency magnetic resonance elastography in distinguishing endometrial and cervical adenocarcinoma[J]. Magn Reson Imaging, 2023, 102: 62-68. DOI: 10.1016/j.mri.2023.05.002.
[19]
XIAO Y Q, CHEN W Y, LONG X, et al. 3D MR elastography-based stiffness as a marker for predicting tumor grade and subtype in cervical cancer[J]. Magn Reson Imaging, 2024, 109: 173-179. DOI: 10.1016/j.mri.2024.03.006.
[20]
LONG L, LIU M L, DENG X J, et al. Tumor stiffness measurement at multifrequency MR elastography to predict lymphovascular space invasion in endometrial cancer[J/OL]. Radiology, 2024, 311(3): e232242[2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/38832881/. DOI: 10.1148/radiol.232242.
[21]
LIU Q, SHI Y, SUN H Z, et al. A preliminary application study of magnetic resonance elastography in the diagnosis of cervical cancer[J]. Chin J Magn Reson Imaging, 2024, 15(8): 12-16, 38. DOI: 10.12015/issn.1674-8034.2024.08.002.
[22]
KARAKAŞ L, POÇAN S, ŞAHIN Ş. Evaluation of stiffness values of normal uterine myometrium by 3T magnetic resonance elastography[J/OL]. Front Med, 2026, 13: 1743585 [2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/41716812/. DOI: 10.3389/fmed.2026.1743585.
[23]
MEYER T, CASTELEIN J, SCHATTENFROH J, et al. Magnetic resonance elastography in a nutshell: Tomographic imaging of soft tissue viscoelasticity for detecting and staging disease with a focus on inflammation[J]. Prog Nucl Magn Reson Spectrosc, 2024, 144/145: 1-14. DOI: 10.1016/j.pnmrs.2024.05.002.
[24]
LIU C, LI M, DONG Z X, et al. Heterogeneous microenvironmental stiffness regulates pro-metastatic functions of breast cancer cells[J]. Acta Biomater, 2021, 131: 326-340. DOI: 10.1016/j.actbio.2021.07.009.
[25]
ZHANG Y L, FU Q, SUN W Y, et al. Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches[J/OL]. J Transl Med, 2025, 23(1): 313 [2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/40075523/. DOI: 10.1186/s12967-025-06306-8.
[26]
CHEN Z H, WANG Y D, FANG Z N, et al. MR elastography characterization of biomechanical properties to enhance enterographic fibrosis diagnosis[J/OL]. Radiology, 2026, 318(2): e252429[2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/41733472/. DOI: 10.1148/radiol.252429.
[27]
MANDUCA A, BAYLY P V, EHMAN R L, et al. MR elastography: Principles, guidelines, and terminology[J]. Magn Reson Med, 2021, 85(5): 2377-2390. DOI: 10.1002/mrm.28627.
[28]
ATAMANIUK V, HAŃCZYK Ł, CHEN J, et al. 3D vector MR elastography applications in small organs[J]. Magn Reson Imaging, 2024, 112: 54-62. DOI: 10.1016/j.mri.2024.06.005.
[29]
MARIAPPAN Y K, GLASER K J, EHMAN R L. Magnetic resonance elastography: a review[J]. Clin Anat, 2010, 23(5): 497-511. DOI: 10.1002/ca.21006.
[30]
MA S Y, WANG R K, QIU S H, et al. MR elastography with optimization-based phase unwrapping and traveling wave expansion-based neural network (TWENN)[J]. IEEE Trans Med Imaging, 2023, 42(9): 2631-2642. DOI: 10.1109/TMI.2023.3261346.
[31]
BUSTIN H, MEYER T, REITER R, et al. ElastoNet: Neural network-based multicomponent MR elastography wave inversion with uncertainty quantification[J/OL]. Med Image Anal, 2025, 105: 103642 [2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/40482562/. DOI: 10.1016/j.media.2025.103642.
[32]
RUSSO C, MORO F, CICCARONE F, et al. Imaging in gynecological disease (30): clinical and ultrasound characteristics of usual-type and variants of leiomyoma[J]. Ultrasound Obstet Gynecol, 2026, 67(3): 385-397. DOI: 10.1002/uog.70130.
[33]
DOLMANS M M, PETRAGLIA F, CATHERINO W H, et al. Pathogenesis of uterine fibroids: current understanding and future directions[J]. Fertil Steril, 2024, 122(1): 6-11. DOI: 10.1016/j.fertnstert.2024.02.048.
[34]
ISLAM M S, AFRIN S, SINGH B, et al. Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids[J/OL]. Clin Transl Med, 2021, 11(7): e475[2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/34323413/. DOI: 10.1002/ctm2.475.
[35]
DE SMIT N S, DE LANGE M E, BOOMSMA M F, et al. Current treatment for symptomatic uterine fibroids: available evidence and therapeutic dilemmas[J]. Lancet, 2025, 406(10498): 91-102. DOI: 10.1016/S0140-6736(25)00728-7.
[36]
WANG L, LIU Y, LIN J F, et al. The predictive effect of quantitative analysis of signal intensity heterogeneity on T2-weighted MR images for high-intensity focused ultrasound treatment of uterine fibroids[J]. Acad Radiol, 2024, 31(7): 2848-2858. DOI: 10.1016/j.acra.2024.04.023.
[37]
HOW J A, JAZAERI A A, WESTIN S N, et al. Translating biological insights into improved management of endometrial cancer[J]. Nat Rev Clin Oncol, 2024, 21(11): 781-800. DOI: 10.1038/s41571-024-00934-7.
[38]
CONCIN N, MATIAS-GUIU X, CIBULA D, et al. ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025[J/OL]. Lancet Oncol, 2025, 26(8): e423-e435 [2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/40744042/. DOI: 10.1016/S1470-2045(25)00167-6.
[39]
LI Z, PENG J L, ZHANG B X, et al. The prognostic and clinical significance of substantial lymphovascular space invasion in early-stage endometrial carcinoma[J/OL]. Eur J Cancer, 2025, 218: 115258 [2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/39893748/. DOI: 10.1016/j.ejca.2025.115258.
[40]
WENZEL H H B, SCHNACK T H, VAN DER AA M A, et al. Risk factors for lymph node metastasis in women with FIGO 2018 IA cervical cancer with a horizontal spread of > 7 mm[J/OL]. Eur J Cancer, 2024, 212: 115063 [2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/39378564/. DOI: 10.1016/j.ejca.2024.115063.
[41]
ABU-RUSTUM N, YASHAR C, AREND R, et al. Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2023, 21(2): 181-209. DOI: 10.6004/jnccn.2023.0006.
[42]
ROCKALL A G, BARWICK T D, WILSON W, et al. Diagnostic accuracy of FEC-PET/CT, FDG-PET/CT, and diffusion-weighted MRI in detection of nodal metastases in surgically treated endometrial and cervical carcinoma[J]. Clin Cancer Res, 2021, 27(23): 6457-6466. DOI: 10.1158/1078-0432.CCR-21-1834.
[43]
ZHANG Q, OUYANG H, YE F, et al. Feasibility of intravoxel incoherent motion diffusion-weighted imaging in distinguishing adenocarcinoma originated from uterine corpus or cervix[J]. Abdom Radiol, 2021, 46(2): 732-744. DOI: 10.1007/s00261-020-02586-4.
[44]
SHAHRYARI M, TZSCHÄTZSCH H, GUO J, et al. Tomoelastography distinguishes noninvasively between benign and malignant liver lesions[J]. Cancer Res, 2019, 79(22): 5704-5710. DOI: 10.1158/0008-5472.CAN-19-2150.
[45]
YANG L, LI J W, ZANG G C, et al. Pin1/YAP pathway mediates matrix stiffness-induced epithelial–mesenchymal transition driving cervical cancer metastasis via a non-Hippo mechanism[J/OL]. Bioeng Transl Med, 2023, 8(1): e10375[2026-03-10]. https://pubmed.ncbi.nlm.nih.gov/36684109/. DOI: 10.1002/btm2.10375.

PREV Research progress on preoperative prediction of endometrial carcinoma molecular subtypes based on MRI radiomics and deep learning
NEXT Research progress in quantitative magnetic resonance imaging for assessing muscle tissue in neuromuscular diseases
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn